Page last updated: 2024-09-05

sorafenib and cp 91149

sorafenib has been researched along with cp 91149 in 1 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(cp 91149)
Trials
(cp 91149)
Recent Studies (post-2010) (cp 91149)
6,5207305,25135017

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)cp 91149 (IC50)
Glycogen phosphorylase, liver formHomo sapiens (human)0.1007
Glycogen phosphorylase, liver formMus musculus (house mouse)0.13

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abo-Ali, EM; Barot, S; Dukhande, VV; Palaguachi, C; Zhou, DL1

Other Studies

1 other study(ies) available for sorafenib and cp 91149

ArticleYear
Inhibition of glycogen catabolism induces intrinsic apoptosis and augments multikinase inhibitors in hepatocellular carcinoma cells.
    Experimental cell research, 2019, 08-15, Volume: 381, Issue:2

    Topics: Amides; Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Energy Metabolism; Glycogen; Glycogen Phosphorylase; Hep G2 Cells; Humans; Indoles; Liver Neoplasms; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Rats; Sorafenib

2019